G48558GR
| Organisms | Evidence |
|---|---|
| Campylobacter jejuni | |
| Leishmania amazonensis | |
| Carassius auratus (goldfish) |
| Gene Symbol | Donor | Acceptor | Reducing terminal(Acceptor) | Reference |
|---|---|---|---|---|
| ST3GAL6 | CMP-Neu5Ac |
|
ceramide | |
| ST6GAL1 | CMP-Neu5Ac |
|
ceramide | |
| ST8SIA6 | CMP-Neu5Ac |
|
Cer | |
| ST6GALNAC2 | CMP-Neu5Ac |
|
ceramide | |
| ST6GALNAC4 | CMP-Neu5Ac |
|
ceramide |
RES 1b:b-dglc-HEX-1:5 2b:b-dgal-HEX-1:5 3b:a-dgro-dgal-NON-2:6|1:a|2:keto|3:d 4s:n-acetyl 5b:b-dgal-HEX-1:5 6s:n-acetyl 7b:b-dgal-HEX-1:5 LIN 1:1o(4+1)2d 2:2o(3+2)3d 3:3d(5+1)4n 4:2o(4+1)5d 5:5d(2+1)6n 6:5o(3+1)7d
| PubMed ID | Title | First Author | Publication Date | Source |
|---|---|---|---|---|
| 12552090 | Reactivity-based one-pot total synthesis of fucose GM 1 oligosaccharide: A sialylated antigenic epitope of small-cell lung cancer | Mong TK | 2003 Jan 27 |
|
| 12183547 | Tolerance to Self Gangliosides Is the Major Factor Restricting the Antibody Response to Lipopolysaccharide Core Oligosaccharides inCampylobacter jejuniStrains Associated with Guillain-Barré Syndrome | Bowes T | 2002 Sep |
|
| 12235148 | Characterization of the second type of human beta-galactoside alpha 2,6-sialyltransferase (ST6Gal II), which sialylates Galbeta 1,4GlcNAc structures on oligosaccharides preferentially. Genomic analysis of human sialyltransferase genes | Takashima S | 2002 Nov 29 |
|
| 11878808 | Immunoglobulin G-class mouse monoclonal antibodies to major brain gangliosides | Schnaar RL | 2002 Mar 15 |
|
| 11980897 | Molecular cloning and expression of a sixth type of alpha 2,8-sialyltransferase (ST8Sia VI) that sialylates O-glycans | Takashima S | 2002 Jul 05 |
|
| 11272699 | Simulation of carbohydrate-protein interactions: Computer-aided design of a second generation GM1 mimic | Bernardi A | 2001 Feb |
|
| 11283076 | Development of an Immunoassay for Rapid Detection of Ganglioside GM 1 Mimicry in Campylobacter jejuni Strains | Prendergast MM | 2001 Apr |
|
| 11062056 | Cloning, expression and gene organization of a human Neu5Ac alpha 2-3Gal beta 1-3GalNAc alpha 2,6-sialyltransferase: hST6GalNAcIV | Harduin-Lepers A | 2000 Nov 15 |
|
| 10762510 | IgG receptor IIa alleles determine susceptibility and severity of Guillain-Barré syndrome | van der Pol WL | 2000 Apr 25 |
|
| 10206952 | Molecular cloning of a novel alpha2,3-sialyltransferase (ST3Gal VI) that sialylates type II lactosamine structures on glycoproteins and glycolipids | Okajima T | 1999 Apr 23 |
|
| Title | Authors | Source | Publication Date | PubMed ID |
|---|---|---|---|---|
| Tissue distribution of EDTA encapsulated within liposomes containing glycolipids or brain phospholipids. |
|
Biochim Biophys Acta | 1978 Jul 3 | 96869 |
| I-Cell disease: isoelectric focusing, concanavalin A-Sepharose 4B binding and kinetic properties of human liver acid beta-D-galactosidases. |
|
Biochim Biophys Acta | 1978 Jan 12 | 413580 |
| An activator stimulating the enzymic hydrolysis of sphingoglycolipids. |
|
J Biol Chem | 1976 Feb 25 | 814123 |
| Purification of G-M-1-ganglioside and ceramide lactoside beta-galactosidase from rabbit brain. |
|
Biochim Biophys Acta | 1975 May 23 | 237552 |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
This work is licensed under Creative Commons Attribution 4.0 International
GlyCosmos Portal v4.5.0
Last updated: April 6, 2026